Boston Scientific: Reclaiming Neurovascular Dominance Through Thrombectomy Precision
Source: SeekingAlpha
2026-01-15 13:45:55 ET
Introduction
Boston Scientific Corporation ( BSX ) is in the news this morning because it entered into a definitive agreement to acquire Penumbra ( PEN ) for around $14.5B in a cash and stock transaction, which is expected to be closed this year, subject to PEN’s shareholder approval and any other “customary closing conditions.”...
Read the full article on Seeking Alpha
For further details see:
Boston Scientific: Reclaiming Neurovascular Dominance Through Thrombectomy Precision
Penumbra Inc.
NASDAQ: PEN
PEN Trading
0.37% G/L:
$335.67 Last:
112,406 Volume:
$336.33 Open:
PEN Latest News
PEN Stock Data
$13,316,119,234
37,517,366
0.09%
173
N/A
Medical Equipment & Supplies
Healthcare
US
Alameda
